Table 2.
Results from logistic regression of uptake of new hepatitis C drugs
| Variable | Odds ratio (95% confidence interval)
|
|||
|---|---|---|---|---|
| With cirrhosis (N = 49,263) |
Without cirrhosis (N = 77,904) |
With HCV/HIV coinfection (N = 11,182) |
With HCV infection only (N = 115,985) |
|
| Race (ref: non-Hispanic White) | ||||
| Black | 0.89 (0.84–0.95)*** | 1.04 (0.99–1.11) | 0.81 (0.72–0.92)*** | 1.00 (0.95–1.05)*** |
| Hispanic | 0.98 (0.91–1.06) | 1.04 (0.95–1.14) | 1.04 (0.90–1.21) | 1.00 (0.94–1.06) |
| HCV/HIV coinfection | 1.06 (0.96–1.17) | 0.98 (0.91–1.06) | ||
| Cirrhosis | 2.37 (2.13–2.65)*** | 2.44 (2.34–2.54)*** | ||
| LIS (low-income subsidy) enrollees | 0.92 (0.86–0.98)*** | 0.95 (0.88–1.02) | 1.08 (0.88–1.32) | 0.92 (0.87–0.97)*** |
| Age | 1.00 (1.00–1.00) | 1.00 (1.00–1.00) | 1.01 (1.00–1.02)** | 1.00 (1.00–1.00) |
| Male | 0.95 (0.9–1.00)* | 0.98 (0.93–1.03) | 1.12 (1.00–1.27)* | 0.96 (0.92–1.00)** |
| Number of chronic conditions | 0.87 (0.86–0.88)*** | 0.88 (0.86–0.90)*** | 0.86 (0.82–0.90)*** | 0.88 (0.86–0.89)*** |
| Having diabetes | 1.23 (1.17–1.29)*** | 1.05 (0.99–1.12) | 1.36 (1.20–1.54)*** | 1.14 (1.09–1.18)*** |
| Having hypertension | 0.94 (0.89–0.99)** | 0.94 (0.88–1.01)* | 0.95 (0.82–1.09) | 0.94 (0.90–0.98)*** |
| Having ischemic heart disease | 1 (0.96–1.06) | 0.97 (0.93–1.03) | 1.23 (1.04–1.46)** | 0.97 (0.94–1.01) |
| Having hyperlipidemia | 0.98 (0.92–1.04) | 1.02 (0.97–1.08) | 1.23 (1.07–1.42)*** | 0.98 (0.94–1.02) |
| Having depression | 1.03 (0.97–1.10) | 1.00 (0.95–1.05) | 0.99 (0.88–1.12) | 1.02 (0.98–1.06) |
| Having congestive heart failure | 0.71 (0.66–0.77)*** | 0.65 (0.59–0.72)*** | 0.63 (0.52–0.75)*** | 0.69 (0.65–0.74)*** |
| Having cataract | 1.29 (1.21–1.37)*** | 1.28 (1.20–1.38)*** | 1.38 (1.17–1.63)*** | 1.28 (1.21–1.34)*** |
| Having chronic obstructive pulmonary disease | 0.80 (0.75–0.85)*** | 0.82 (0.77–0.88)*** | 0.78 (0.67–0.91)*** | 0.81 (0.78–0.85)*** |
| Below median household income | 0.89 (0.85–0.94)*** | 0.93 (0.87–0.99)** | 1.03 (0.92–1.14) | 0.9 (0.85–0.94)*** |
| Percent college educated | 1.00 (1.00–1.01)*** | 1.00 (1.00–1.01)*** | 1.00 (1.00–1.01) | 1.00 (1.00–1.01)*** |
| Urban area | 1.07 (1.00–1.16)* | 1.02 (0.95–1.09) | 1.32 (1.05–1.66)** | 1.03 (0.97–1.09) |
| Applying prior authorization | 1.39 (0.98–1.97)* | 0.83 (0.52–1.33) | 1.01 (0.32–3.23) | 1.08 (0.83–1.42) |
| Enhanced plan | 1.24 (1.13–1.35)*** | 1.22 (1.11–1.34)*** | 1.17 (0.89–1.53) | 1.23 (1.15–1.32)*** |
| Gap coverage plan | 1.04 (0.93–1.16) | 0.94 (0.80–1.09) | 0.91 (0.63–1.30) | 1.00 (0.90–1.12) |
| Deduct | 1.07 (0.99–1.16)* | 1.06 (0.96–1.16) | 0.91 (0.71–1.17) | 1.08 (1.01–1.16)** |
| Region (ref: Northeast) | ||||
| Midwest | 1.08 (0.97–1.20) | 1.04 (0.96–1.12) | 1.02 (0.82–1.27) | 1.05 (0.97–1.14) |
| South | 0.90 (0.83–0.98)** | 0.95 (0.87–1.02) | 0.76 (0.62–0.92)*** | 0.94 (0.88–1.01)* |
| West | 0.89 (0.81–0.98)** | 0.76 (0.70–0.83)*** | 0.78 (0.60–1.02)* | 0.83 (0.77–0.90)*** |
***
p < 0.01,
**
p < 0.05, and
*
p < 0.10; standard errors are clustered within a plan